Back to ALLIANCEBERNSTEIN L.P. ALLIANCEBERNSTEIN L.P.

AXSMAXSM

Showing 8 of 29 quarters

Position history for ALLIANCEBERNSTEIN L.P.ALLIANCEBERNSTEIN L.P.'s holdings in AXSOME THERAPEUTICS INC.

Yes. AllianceBernstein holds 85,716 shares of AXSM (Axsome Therapeutics), worth $14.5M, as of its Q2 2026 13F filing. It increased the position by 22,894 shares (+36.4%) from Q1 2026. AllianceBernstein has held AXSM since Q2 2019, across 29 quarterly 13F filings.

Current Value

$14.5M

Current Shares

85,716

Total Value Change

+$3.3M

Total Shares Change

-39,262

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
85,716
+36.4%
$14.5M0.0%$244.77
37
2026-Q1
Increased
62,822
+18.2%
$11.5M0.0%$169.02
33
2025-Q4
Decreased
53,140
-15.7%
$9.7M0.0%$182.64
0
2025-Q3
Increased
63,065
+37.1%
$7.7M0.0%$121.45
36
2025-Q2
Decreased
45,982
-25.2%
$4.8M0.0%$104.39
0
2025-Q1
Increased
61,471
+31.9%
$7.2M0.0%$116.63
35
2024-Q4
Decreased
46,590
-62.7%
$3.9M0.0%$84.61
0
2024-Q3
Decreased
124,978
-25.9%
$11.2M0.0%$89.87
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used